Skip to main content
Log in

Effect of Sulfation and Molecular Weight on Anticoagulant Activity of Dextran

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Sulfation (to 2.8) of dextrans with molecular weight of 150 and 20 kDa was followed by the appearance of anticoagulant activity that increased with decreasing their molecular weight and did not depend on antithrombin, plasma inhibitor of serine proteases of the blood coagulation system. Antithrombin activity of dextran sulfate with a molecular weight of 20 kDa reached 12.6-15.3 U/mg. Dextran sulfates with molecular weights of 20 and 150 kDa did not potentiate ADP-induced human platelet aggregation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Makarov VA, Spasov AA, Plotnikova MB, Belozerskaya GG, Vasil’eva TM, Drozd NN, svistunov AA, Kucheryavenko AF, Malykhina LS, Naumenko LV, Nevedrova OE, Petrukhina GN, Aliev OI, Plotnikova TM. Methodical recommendations for testing drugs affecting hemostasis. Manual for Preclinical Studies of New Pharmacological Substances. Part I, Mironov AN, ed. Moscow, 2012. P. 453-479. Russian.

  2. Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194:927-929.

    Article  CAS  PubMed  Google Scholar 

  3. de Raucourt E, Mauray S, Chaubet F, Maiga-Revel O, Jozefowicz M, Fischer A.M. Anticoagulant activity of dextran derivatives. J. Biomed. Mater. Res. 1998;41(1):49-57.

    Article  CAS  PubMed  Google Scholar 

  4. Jones CI, Payne DA, Hayes PD, Naylor AR, Bell PR, Thompson MM, Goodall AH. The antithrombotic effect of dextran-40 in man is due to enhanced fibrinolysis in vivo. J. Vasc. Surg. 2008;48(3):715-722.

    Article  PubMed  Google Scholar 

  5. Robless P, Okonko D, Mikhailidis DP, Stansby G. Dextran 40 reduces in vitro platelet aggregation in peripheral arterial disease. Platelets. 2004;15(4):215-222.

    Article  CAS  PubMed  Google Scholar 

  6. Saito A. Heparin cofactor II is degraded by heparan sulfate and dextran sulfate. Biochem. Biophys. Res. Commun. 2015;457(4):585-588.

    Article  CAS  PubMed  Google Scholar 

  7. Teien AN, Lie M. Evaluation of an amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III. Thromb. Res. 1977;10(3):399-410.

    Article  CAS  PubMed  Google Scholar 

  8. Yu P, Gu H. Bioactive substances from marine fishes, shrimps, and algae and their functions: present and future. Crit. Rev. Food. Sci. Nutr. 2015;55(8):1114-1136.

    Article  CAS  PubMed  Google Scholar 

  9. Zeerleder S, Mauron T, Lämmle B, Wuillemin WA. Effect of low-molecular weight dextran sulfate on coagulation and platelet function tests. Thromb. Res. 2002;105(5):441-446.

    Article  CAS  PubMed  Google Scholar 

  10. Zhu F, Heditke S, Kurtzberg J, Waters-Pick B, Hari P, Margolis DA, Keever-Taylor CA. Hydroxyethyl starch as a substitute for dextran 40 for thawing peripheral blood progenitor cell products. Cytotherapy. 2015;17(12):1813-1819.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. N. Drozd.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 162, No. 10, pp. 456-459, October, 2016

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Drozd, N.N., Logvinova, Y.S., Torlopov, M.A. et al. Effect of Sulfation and Molecular Weight on Anticoagulant Activity of Dextran. Bull Exp Biol Med 162, 462–465 (2017). https://doi.org/10.1007/s10517-017-3640-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-017-3640-2

Key Words

Navigation